- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02428426
Mucosal Microbiome in Human Gastric Intestinal Metaplasia and Duodenal Tissue.
April 23, 2015 updated by: Yanqing Li, Shandong University
To investigate the mucosal microbiome in human gastric intestinal etaplasia and duodenal tissue.
Study Overview
Status
Unknown
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: li yanqing, PhD,MD
- Phone Number: 82169508 86-531-82169236
- Email: liyanqing@sdu.edu.cn
Study Locations
-
-
Shandong
-
Jinan, Shandong, China, 250012
- Recruiting
- Department of Gastroenterology, Qilu Hospital, Shandong University
-
Contact:
- Yanqing Li, PhD. MD.
- Phone Number: 82169508 86-531-82169236
- Email: qiluliyanqing@gmail.com
-
Principal Investigator:
- Yanqing Li, PhD. MD.
-
Sub-Investigator:
- Jian Gong, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Prospective patients scheduled for pCLE examination at Qilu Hospital, Shandong University
Description
Inclusion Criteria:
- Patients scheduled for gastroendoscopy examination Aged between 18 and 80 years old
Exclusion Criteria:
- Antibiotic, probiotic or prebiotic usage within 2months,gastric inhibitor usage within 1 month Esophageal, gastric or duodenal cancer or other malignancy History of upper GI tract surgery Coagulopathy or bleeding disorders Allergy to fluorescein sodium Pregnant or breast-feeding (for females) Impaired renal function
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
gastric intestinal metaplasia
patients were diagnosed gastric intestinal metaplasia
|
|
gastritis
patients were diagnosed non atrophic gastritis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The operational taxonomy units in gastric Intestinal Metaplasia and and Duodenal mucosal microbiome
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2014
Primary Completion (Anticipated)
July 1, 2015
Study Completion (Anticipated)
July 1, 2015
Study Registration Dates
First Submitted
April 23, 2015
First Submitted That Met QC Criteria
April 23, 2015
First Posted (Estimate)
April 28, 2015
Study Record Updates
Last Update Posted (Estimate)
April 28, 2015
Last Update Submitted That Met QC Criteria
April 23, 2015
Last Verified
April 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2015SDU-QILU-G04
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastric Intestinal Metaplasia
-
Shandong UniversityUnknownGastric Intestinal Metaplasia | Confocal Laser Endomicroscopy | Biopsy | Operative Link on Gastric Intestinal MetaplasiaChina
-
Xijing Hospital of Digestive DiseasesCompleted
-
Shandong UniversityUnknownGastric Intestinal MetaplasiaChina
-
Shandong UniversityUnknownGastric Intestinal MetaplasiaChina
-
Shandong UniversityUnknownGastric Intestinal MetaplasiaChina
-
Shandong UniversityCompletedGastric Intestinal MetaplasiaChina
-
Shandong UniversityUnknownGastric Intestinal MetaplasiaChina
-
King Chulalongkorn Memorial HospitalCompletedGastric Intestinal MetaplasiaThailand
-
King Chulalongkorn Memorial HospitalUnknownGastric Intestinal MetaplasiaThailand
-
Shandong UniversityNot yet recruitingHelicobacter Pylori | the Operative Link on Gastric Intestinal Metaplasia | Operative Link on Gastric Intestinal AssessmentChina
Clinical Trials on endomicroscopy, targeted biopsy and 16s rRNA gene sequencing
-
Shandong UniversityUnknownIntestinal Metaplasia | Mucosal Microbiome | H.Pylori | Gastric NeoplasiaChina
-
Gomel State Medical UniversityRecruiting
-
Reproductive Medicine Associates of New JerseyCompleted
-
Chinese University of Hong KongRecruiting
-
Yiqi DuUnknown
-
Atlas BiomedTerminatedParkinson Disease | Genetic PredispositionRussian Federation
-
Atlas BiomedCompletedStudy of the Genome, Gut Metagenome and Lifestyle of Patients With Incident Type 2 Diabetes MellitusDiabetes Mellitus, Type 2 | Genetic Predisposition | MetagenomeRussian Federation
-
University Hospital, Basel, SwitzerlandNot yet recruitingInfertility, Female | Non Specific Chronic EndometritisSwitzerland
-
Qilu Hospital of Shandong UniversityCompletedPancreatic Ductal Adenocarcinoma (PDAC)China